Veronica Bautista-Pina
Overview
Explore the profile of Veronica Bautista-Pina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
947
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bornstein-Quevedo L, de Anda-Gonzalez J, Lara-Torres C, Flores-Gutierrez J, Dorantes-Heredia R, Bautista-Pina V, et al.
J Pers Med
. 2024 May;
14(5).
PMID: 38793049
The article discusses the importance of accurately distinguishing HER2-low from HER2-negative breast cancer, as novel ADCs have demonstrated activity in a large population of patients with HER2-low-expressing BC. While current...
2.
Martinez-Cannon B, Soto-Perez-de-Celis E, Erazo Valle-Solis A, Arce-Salinas C, Bargallo-Rocha E, Bautista-Pina V, et al.
Clin Transl Oncol
. 2022 Aug;
25(1):151-159.
PMID: 35986133
Background: Adherence to clinical practice guidelines improves outcomes for patients with breast cancer. However, their implementation may not be feasible in low- and middle-income countries. This study aimed to evaluate...
3.
Tejeda M, Canto P, Tenorio-Torres A, Orozco-Arguelles L, Coral-Vazquez R, Zentella-Dehesa A, et al.
J Clin Pathol
. 2021 Jun;
PMID: 34083413
Aim: To analyse the fibronectin type III domain containing 5 (FNDC5)/irisin expression in tumour tissue of postmenopausal women presenting breast cancer and different body mass indexes (BMIs), proposing that obesity...
4.
Romero-Cordoba S, Salido-Guadarrama I, Rebollar-Vega R, Bautista-Pina V, Dominguez-Reyes C, Tenorio-Torres A, et al.
Nat Commun
. 2021 Apr;
12(1):2245.
PMID: 33854067
Breast cancer is a heterogeneous pathology, but the genomic basis of its variability remains poorly understood in populations other than Caucasians. Here, through DNA and RNA portraits we explored the...
5.
Cardenas Cardenas E, Tenorio-Torres A, Mendez J, Orozco-Arguelles L, Leal-Garcia M, Coral-Vazquez R, et al.
Ann Diagn Pathol
. 2021 Mar;
60:151705.
PMID: 33685748
The aim of this study was to investigate the expression of leptin (LEP) and its receptor (LEPR) in breast cancer tissue of postmenopausal women with different body mass indexes (BMI),...
6.
Perez-Amado C, Tovar H, Gomez-Romero L, Beltran-Anaya F, Bautista-Pina V, Dominguez-Reyes C, et al.
Front Oncol
. 2020 Nov;
10:572954.
PMID: 33194675
Studies have suggested a potential role of somatic mitochondrial mutations in cancer development. To analyze the landscape of somatic mitochondrial mutation in breast cancer and to determine whether mitochondrial DNA...
7.
Orozco-Arguelles L, De Los Santos S, Tenorio-Torres A, Mendez J, Leal-Garcia M, Coral-Vazquez R, et al.
J Clin Pathol
. 2020 Aug;
74(9):571-576.
PMID: 32848015
Aim: To analyse the expression of adiponectin (ADIPOQ), and its receptors ADIPOR1 and ADIPOR2, in breast cancer tissue of postmenopausal women with different body mass indexes (BMIs). Subjects And Methods:...
8.
Cedro-Tanda A, Rios-Romero M, Romero-Cordoba S, Cisneros-Villanueva M, Rebollar-Vega R, Alfaro-Ruiz L, et al.
Sci Rep
. 2020 Aug;
10(1):13146.
PMID: 32753692
Breast cancer is the most commonly diagnosed neoplasm in women worldwide with a well-recognized heterogeneous pathology, classified into four molecular subtypes: Luminal A, Luminal B, HER2-enriched and Basal-like, each one...
9.
Villarreal-Garza C, Lopez-Martinez E, Deneken-Hernandez Z, Maffuz-Aziz A, Munoz-Lozano J, Barragan-Carrillo R, et al.
PLoS One
. 2020 Mar;
15(3):e0228884.
PMID: 32160201
Objective: To evaluate the change in adjuvant therapeutic decision in a cohort of young women with breast cancer discussed by a multidisciplinary team, before and after EndoPredict testing. Patients And...
10.
Beltran-Anaya F, Romero-Cordoba S, Rebollar-Vega R, Arrieta O, Bautista-Pina V, Dominguez-Reyes C, et al.
Mol Oncol
. 2019 Jan;
13(4):909-927.
PMID: 30648789
Triple negative breast cancer (TNBC) represents an aggressive phenotype with poor prognosis compared with ER, PR, and HER2-positive tumors. TNBC is a heterogeneous disease, and gene expression analysis has identified...